
|Articles|October 18, 2007
First integrase inhibitor Isentress gets regulatory green light
Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Advertisement
Accelerated approval for Merck's raltegravir (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
How Pharmacists Take Control of Medical Billing
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























